- Main
Discovery of widespread type I and type V CRISPR-Cas inhibitors
- Marino, Nicole D;
- Zhang, Jenny Y;
- Borges, Adair L;
- Sousa, Alexander A;
- Leon, Lina M;
- Rauch, Benjamin J;
- Walton, Russell T;
- Berry, Joel D;
- Joung, J Keith;
- Kleinstiver, Benjamin P;
- Bondy-Denomy, Joseph
Published Web Location
https://doi.org/10.1126/science.aau5174Abstract
Bacterial CRISPR-Cas systems protect their host from bacteriophages and other mobile genetic elements. Mobile elements, in turn, encode various anti-CRISPR (Acr) proteins to inhibit the immune function of CRISPR-Cas. To date, Acr proteins have been discovered for type I (subtypes I-D, I-E, and I-F) and type II (II-A and II-C) but not other CRISPR systems. Here, we report the discovery of 12 acr genes, including inhibitors of type V-A and I-C CRISPR systems. AcrVA1 inhibits a broad spectrum of Cas12a (Cpf1) orthologs-including MbCas12a, Mb3Cas12a, AsCas12a, and LbCas12a-when assayed in human cells. The acr genes reported here provide useful biotechnological tools and mark the discovery of acr loci in many bacteria and phages.
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.